HOME >> BIOLOGY >> NEWS
Eating After Exertion May Be A Key To Speeding Body's Recovery

CHAMPAIGN, Ill. -- After you've run that marathon, take time to eat. A post-exercise meal containing amino acids and carbohydrates may speed your body's recovery and enhance peak-performance levels, according to University of Illinois scientists.

In a series of studies, researchers also found that eating oat-based cereal before exercise can help fight fatigue and feelings of hunger. The pre-exercise findings, based on human studies, were published in the American Journal of Clinical Nutrition and in the Journal of Nutrition.

The post-exercise findings, involving rats, will be presented April 6-9 by U. of I. graduate students Tracy Gautsch and Josh Anthony at the American Society for Nutritional Sciences annual meeting in New Orleans.

Healthy adults consumed nothing or a cereal with oat, wheat or corn meal 90 minutes before a 90-minute low-level cycling exercise followed by a competitive 5-mile ride. Those who had eaten reported less fatigue and less hunger after the workouts. Performance levels were not affected in this study, funded by Quaker Oats Co., but initial metabolic changes suggested a pattern of improvement.

The goal of the research was to alter blood chemistry, specifically the ratio of tryptophan, an essential amino acid, to large neutral amino acids, said principal investigator Donald K. Layman, a U. of I. professor of nutrition. Tryptophan levels in the blood help regulate the release of serotonin in the brain, causing lethargy and fatigue.

"The oat-based cereal allowed us to increase the denominator in the ratio," Layman said. "Raising the level of large neutral amino acids should reduce the amount of tryptophan getting into the brain and reduce feelings of fatigue."

The oat cereal worked to reduce the rise of glucose and insulin, allowing for a stable blood chemistry that promoted the efficient use of free fatty acids, Layman said. These effects, he added, are probably derived from the solubl
'"/>

Contact: Jim Barlow, Life Sciences Editor
b-james3@uiuc.edu
217-333-5802
University of Illinois at Urbana-Champaign
13-Mar-1997


Page: 1 2

Related biology news :

1. Eating bats linked to neurological disease
2. Eating eggs may protect against breast cancer
3. Eating transgenic sausages
4. Eating less may protect nerve cells
5. Eating more fish and n3 fatty acids associated with reduced risk of stroke for women
6. Eating recommended foods associated with decrease in risk of mortality for women
7. Eating soy can lead to dramatic declines in cholesterol, Wake Forest study shows
8. Eating contaminated Great Lakes sport fish does not inhibit lactation, UB study finds
9. Eating proper foods at right time after exercise can speed recovery
10. UF Researcher: Athletes Likely To Have Symptoms Of Eating Disorders
11. First Dinosaur Embryo Skin Discovered -- Unhatched Embryos Are First Ever Found Of Giant-Plant Eating Dinosaurs

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Eating After Exertion May Key Speeding Body Recovery

(Date:11/21/2014)... According to a new market research report ... Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), End ... - Global Forecasts to 2020", published by MarketsandMarkets, The ... $25 Billion in 2014 and is expected to reach ... 8.69%. Browse 116 market data Tables and ...
(Date:11/21/2014)... JOSE, Calif. , Nov. 20, 2014   ... global leader in microcontroller (MCU) and touch technology solutions, ... digital temperature sensors with the widest V cc ... delivers higher temperature accuracy and faster I 2 C ... registers and serial EEPROM memory making them ideal for ...
(Date:11/18/2014)... YORK , Nov. 18, 2014   ... identity authentication solutions, and MorphoTrust USA ... and services, today announced a strategic partnership to ... enterprise, motor vehicle administration (MVA), airport screening and ... in identity-related solutions, MorphoTrust serves consumers through a ...
Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
(Date:12/17/2014)... Ipsen Biopharmaceuticals, Inc., an affiliate ... IPSEY), today announced that Somatuline® Depot® (lanreotide) ... approved by the U.S. Food and Drug Administration ... (GEP-NETs) in adult patients with unresectable, well or ... improve progression-free survival (PFS). , “The approval of ...
(Date:12/17/2014)... IN (PRWEB) December 17, 2014 ... Laboratory Excellence following its most recent COLA inspection. ... by COLA, a national healthcare accreditation organization. Accreditation ... standards of quality in day-to-day operations, demonstrate continued ... pass a rigorous on-site laboratory survey. ...
(Date:12/17/2014)... 2014  Vermillion, Inc. (NASDAQ: VRML ), ... announced the next step in its expanded strategy to ... with the naming of current Chief Operating Officer, ... while current Chairman of the Board and CEO ... These changes are effective January 1, 2015. ...
(Date:12/17/2014)... 17, 2014 Tigercat Pharma, Inc. today ... evaluating the investigational oral NK-1 receptor antagonist VPD-737 ... chronic itch who are unresponsive or inadequately responsive ... steroids and antihistamines. The primary ... Scale (VAS) itch score from baseline, comparing drug ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
Cached News: